Computational model for nanocarrier binding to endothelium validated using in vivo, in vitro, and atomic force microscopy experiments

A computational methodology based on Metropolis Monte Carlo (MC) and the weighted histogram analysis method (WHAM) has been developed to calculate the absolute binding free energy between functionalized nanocarriers (NC) and endothelial cell (EC) surfaces. The calculated NC binding free energy landscapes yield binding affinities that agree quantitatively when directly compared against analogous measurements of specific antibody-coated NCs (100 nm in diameter) to intracellular adhesion molecule-1 (ICAM-1) expressing EC surface in in vitro cell-culture experiments. The effect of antibody surface coverage (σs) of NC on binding simulations reveals a threshold σs value below which the NC binding affinities reduce drastically and drop lower than that of single anti-ICAM-1 molecule to ICAM-1. The model suggests that the dominant effect of changing σs around the threshold is through a change in multivalent interactions; however, the loss in translational and rotational entropies are also important. Consideration of shear flow and glycocalyx does not alter the computed threshold of antibody surface coverage. The computed trend describing the effect of σs on NC binding agrees remarkably well with experimental results of in vivo targeting of the anti-ICAM-1 coated NCs to pulmonary endothelium in mice. Model results are further validated through close agreement between computed NC rupture-force distribution and measured values in atomic force microscopy (AFM) experiments. The three-way quantitative agreement with AFM, in vitro (cell-culture), and in vivo experiments establishes the mechanical, thermodynamic, and physiological consistency of our model. Hence, our computational protocol represents a quantitative and predictive approach for model-driven design and optimization of functionalized nanocarriers in targeted vascular drug delivery.

[1]  E. Verrier The vascular endothelium: friend or foe? , 1993, The Annals of thoracic surgery.

[2]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  Molly S. Shoichet,et al.  Tunable immunonanoparticle binding to cancer cells: thermodynamic analysis of targeted drug delivery vehicles , 2009 .

[4]  Phapanin Charoenphol,et al.  Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.

[5]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[6]  Dietmar W. Siemann,et al.  Vascular targeted therapies in oncology , 2008, Cell and Tissue Research.

[7]  S. Mitragotri,et al.  Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.

[8]  M. Davies,et al.  The vascular endothelium. A new horizon. , 1993, Annals of surgery.

[9]  S. Radford,et al.  Nucleation of protein fibrillation by nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[10]  Stephen C. Cowin,et al.  Mechanotransduction and flow across the endothelial glycocalyx , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Michael L. Smith,et al.  Estimation of viscosity profiles using velocimetry data from parallel flows of linearly viscous fluids: application to microvascular haemodynamics , 2004, Journal of Fluid Mechanics.

[12]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Samir Mitragotri,et al.  Role of Particle Size in Phagocytosis of Polymeric Microspheres , 2008, Pharmaceutical Research.

[14]  George M. Whitesides,et al.  Designing a polyvalent inhibitor of anthrax toxin , 2001, Nature Biotechnology.

[15]  Daniel A Hammer,et al.  Quantifying nanoparticle adhesion mediated by specific molecular interactions. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[16]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[17]  R. Kane,et al.  Statistical pattern matching facilitates the design of polyvalent inhibitors of anthrax and cholera toxins , 2006, Nature Biotechnology.

[18]  David S. Long,et al.  Near-Wall μ-PIV Reveals a Hydrodynamically Relevant Endothelial Surface Layer in Venules In Vivo , 2003 .

[19]  S. Santra,et al.  Role of nanoparticle valency in the nondestructive magnetic-relaxation-mediated detection and magnetic isolation of cells in complex media. , 2009, Journal of the American Chemical Society.

[20]  B. Roux The calculation of the potential of mean force using computer simulations , 1995 .

[21]  Kwang-Hwi Cho,et al.  BIOPHYSICS AND COMPUTATIONAL BIOLOGY , 2009 .

[22]  V. Moy,et al.  Force spectroscopy of the leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. , 2002, Biophysical journal.

[23]  Silvia Muro,et al.  Endothelial Targeting of High-Affinity Multivalent Polymer Nanocarriers Directed to Intercellular Adhesion Molecule 1 , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  Alison Thomas A new horizon , 2001 .

[25]  Berend Smit,et al.  Understanding molecular simulation: from algorithms to applications , 1996 .

[26]  R. Kane,et al.  Polyvalent inhibitors of anthrax toxin that target host receptors , 2006, Proceedings of the National Academy of Sciences.

[27]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[28]  A. Mulivor,et al.  Role of glycocalyx in leukocyte-endothelial cell adhesion. , 2002, American journal of physiology. Heart and circulatory physiology.

[29]  Jens Carlsson,et al.  Absolute and relative entropies from computer simulation with applications to ligand binding. , 2005, The journal of physical chemistry. B.

[30]  B. Roux,et al.  Calculation of absolute protein-ligand binding free energy from computer simulations. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Evans,et al.  Dynamic strength of molecular adhesion bonds. , 1997, Biophysical journal.

[32]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[33]  A. Shah Vascular endothelium. , 1992, British journal of hospital medicine.

[34]  R. Radhakrishnan,et al.  The Role of Glycocalyx in Nanocarrier-Cell Adhesion Investigated Using a Thermodynamic Model and Monte Carlo Simulations. , 2007, The journal of physical chemistry. C, Nanomaterials and interfaces.

[35]  O. McCarty,et al.  Single Molecule Characterization of P-selectin/Ligand Binding* 210 , 2003, The Journal of Biological Chemistry.

[36]  P Bongrand,et al.  Cell adhesion. Competition between nonspecific repulsion and specific bonding. , 1984, Biophysical journal.

[37]  David Vance,et al.  The design of polyvalent scaffolds for targeted delivery. , 2009, Advanced drug delivery reviews.

[38]  Ali Khademhosseini,et al.  Nanobiotechnology drug deliery and tissue engineering drug delivery and tissue engineering , 2006 .

[39]  Silvia Muro,et al.  Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. , 2009, Biorheology.